FDA commissioner watch intensifies as FDA reform bill nears completion.
This article was originally published in The Tan Sheet
Executive Summary
FDA COMMISSIONER WATCH INTENSIFIES: COMPLETION OF FDA REFORM BILL is a logical time for a White House nomination to be for-warded to the Senate for confirmation hearings. Any delays would suggest the nomination of HHS' preferred candidate, FDA Lead Deputy Commissioner Michael Friedman, MD, has run into roadblocks.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning